IKT

1.3201.54%
AK

Arvind Kush

Independent Director

Mr. Arvind Kush serves as an Independent Director at Inhibikase Therapeutics, Inc. since October 21, 2024. Mr. Kush serves as the Chief Financial Officer, Chief Business Officer & Secretary of Candid Therapeutics, Inc. Mr. Kush served as the Chief Financial Officer of RayzeBio, Inc. from November 2021. He joined RayzeBio, Inc. in January 2022. He has experience working with Bank of America Securities. Mr. Kush served as Managing Director in the Healthcare Group in the Global Corporate Investment Banking Division at BofA Securities from February 2018 until November 2021, advising biopharmaceutical companies on strategic and financing transactions. From July 2008 until January 2018, Mr. Kush served in roles of increasing responsibilities in the healthcare investment banking team at BofA Securities and its predecessor companies, serving as director. From January 2004 until June 2006, Mr. Kush served as senior software engineer at Caritor India Pvt. Ltd. (now NTT Data Services). Mr. Kush earned a B.E. in computer science from Visvesvaraya Technological University, India and an M.B.A. from the Goizueta Business School at Emory University.

Positions